Today on TheBrief
Fast, reliable briefs on the latest medical research. Each one gives you the finding, the population it applies to, what it changes in practice, and a link straight to the original source.
Health Policy
FDA materials recommend keeping three unapproved peptides off the 503A Bulks List, a step that could sharply restrict traditional pharmacies’ ability to compound them from bulk ingredients.
Dr. Abu Bakar · September 20, 2026 · 6 min
Cardiology
A 2026 meta-analysis found that digitalis glycosides reduced worsening heart failure events, but not cardiovascular death, reinforcing a selective rather than routine role.
Dr. Abu Bakar · 7 min read
Endocrinology & Metabolism
WHO is calling for stronger safety monitoring as GLP-1 use for weight loss grows worldwide. Clinicians need reliable prescribing, follow-up and adverse-event reporting systems.
Dr. Abu Bakar · 7 min read
Clinical Briefs
The FDA reported 184 serious injuries and no deaths involving specified Medtronic and Given Imaging esophageal pH capsule delivery devices. Gastroenterology services should review inventory, workflows and follow-up.
Rayan Salih · 7 min read
Cardiology
FDA approval adds baxdrostat as an aldosterone-targeted option for adults whose hypertension remains uncontrolled on combination therapy.
Rayan Salih · 7 min read
Heart and vascular medicine
Trial results, device approvals and practice guidance across cardiology, interventional care and vascular medicine.
Cancer care and research
Practice-changing oncology and hematology research, from early detection through survivorship.
Brain, nerve and cognitive care
Neurology and neuroscience briefs covering diagnosis, disease-modifying therapy and long-term management.
Diabetes, obesity and hormone health
Metabolic medicine: glycemic management, GLP-1 therapeutics, thyroid disease and endocrine practice.
OBGYN and women's medicine
Obstetric, gynecologic and women's health evidence across the reproductive lifespan.
Psychiatry and behavioral medicine
Psychiatry, behavioral health and sleep medicine research with an eye on what changes in clinic.
Infection, immunity and prevention
Infectious disease, immunology and infection prevention, from outbreak response to vaccine evidence.
Regulation, coverage and access
Policy, payment and public health decisions that shape how clinicians practice and patients get care.
Technology at the bedside
Medical devices, diagnostics, digital health and AI tools moving from pipeline into practice.
Reporting from the meetings
Late-breaking data and session highlights from the major medical congresses.
Across the specialties
Concise evidence briefs from across internal medicine, surgery, pediatrics and primary care.
Infectious Disease
WHO has issued a unified framework for clinicians and outbreak teams managing Ebola and Marburg disease, linking supportive care with infection prevention, workforce protection, and coordinated response.
Rayan Salih · 7 min read
Oncology
Interim phase 3 results favor adding sacituzumab tirumotecan to first-line pembrolizumab for PD-L1-positive advanced NSCLC, but survival, safety and generalizability remain unsettled.
Rayan Salih · 6 min read
Oncology
FDA accelerated approval applies to previously treated, advanced non-squamous NSCLC with qualifying activating mutations in the HER2 tyrosine kinase domain—not every ERBB2 alteration.
Rayan Salih · 6 min read
Infectious Disease
A CDC alert describes increased reports of human rabies exposures nationwide. Clinicians need a rapid workflow for exposure assessment, public health consultation and correctly delivered prophylaxis.
Rayan Salih · 7 min read
Oncology
The FDA approved an allogeneic regulatory T-cell therapy for adults with hematologic malignancies undergoing matched-donor stem cell transplantation. Programs must assess eligibility, logistics and safety readiness.
Rayan Salih · 6 min read
Oncology
Ivonescimab plus chemotherapy prolonged median overall survival after EGFR-TKI therapy, but toxicity, generalizability and US regulatory status shape its relevance.
Rayan Salih · 7 min read
Innovation & Devices
The FDA has cleared Dexcom Stelo for over-the-counter use in people aged 2 years and older who do not use insulin, extending nonprescription continuous glucose monitoring to children.
Rayan Salih · 6 min read
Health Policy
An FDA-posted recall of one morphine injection lot shows why hospitals need closed-loop alerts, secure quarantine and lot-level verification when a mislabeled container may hold hydromorphone.
Rayan Salih · 6 min read
One story a day
One health journey each morning — no advice, no alarm, just company for the road.
Neurology
A multicenter phase 3 trial supports intravenous fosphenytoin for rapid relief during severe trigeminal neuralgia attacks. Its monitored administration and off-label US status limit where it can be used.
Dr. Abu Bakar · 6 min read
Clinical Briefs
FDA approval of RefluxStop requires a prospective study of 200 patients with GERD, reflecting unresolved questions about long-term implant safety, effectiveness and durability.
Dr. Abu Bakar · 6 min read
Cardiology
A 2026 meta-analysis estimated 32% lower odds of major cardiovascular events with semaglutide. The result supports cardiovascular benefit discussions but requires context on heterogeneity, absolute risk and indication.
Dr. Abu Bakar · 6 min read
Neurology
Small studies report improvements in fatigue, cognition, sleep and pain among people with long COVID, but a systematic review rates the evidence as low certainty.
Dr. Abu Bakar · 6 min read
Endocrinology & Metabolism
In a randomized trial, retatrutide monotherapy lowered glycated hemoglobin and body weight in adults with type 2 diabetes inadequately controlled by diet and exercise.
Dr. Abu Bakar · 6 min read
Infectious Disease
IDSA’s 2026 guidance reviews treatment of major drug-resistant pathogens and highlights decisions clinicians and stewardship programs should reassess as evidence evolves.
Dr. Abu Bakar · 7 min read
Amanda Gray
Contributing writer · PA
A board-certified Physician Assistant who has been practicing medicine since 2008. My clinical experience includes occupational medicine, urgent care, family medicine, and cardiology, with the majority of my career…
Egbavwe Pela
Contributing writer
Dr. Abu Bakar
Contributing writer · PharmD, PhD (Pharmacology)
A Pharm-D and PhD in Pharmacology from Punjab University College of Pharmacy, and I have worked as a registered hospital pharmacist at Jinnah Hospital Lahore. Over the past six years in clinical practice, I have seen…
Rayan Salih
Contributing writer · PharmD, RPh
Rayan is a pharmacist, life science communicator, and health policy researcher with a deep interest in ensuring patient access to innovative and life-changing therapies. She obtained her PharmD at Rosalind Franklin…